A 2019 rule-change by the US medical devices regulator aimed at encouraging innovations targeting insomnia and anxiety is bearing fruit: Neurovalens, a Belfast-based startup that’s been developing technology to deliver non-invasive electrical stimulation of the brain and nervous system for almost a decade, has just had its second head-mounted treatment device cleared by the FDA. […]
© 2024 TechCrunch. All rights reserved. For personal use only.
About The Author
